Prognostic performance of kinetic changes of high-sensitivity troponin T in acute coronary syndrome and in patients with increased troponin without acute coronary syndrome

被引:8
|
作者
Mueller, Matthias [1 ]
Biener, Moritz [1 ]
Vafaie, Mershad [1 ]
Blankenberg, Stefan [2 ]
White, Harvey D. [3 ]
Katus, Hugo A. [1 ]
Giannitsis, Evangelos [1 ]
机构
[1] Univ Heidelberg Hosp, Dept Internal Med 3, Heidelberg, Germany
[2] Univ Heart Ctr Hamburg, Dept Gen & Intervent Cardiol, Hamburg, Germany
[3] Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland, New Zealand
关键词
High-sensitivity troponin T; Prognosis; ACS; Non-ACS; Kinetic changes; MYOCARDIAL-INFARCTION; RISK STRATIFICATION; CHEST-PAIN; I ASSAY; ABSOLUTE; DISEASE; RECLASSIFICATION; BIOMARKER; OUTCOMES;
D O I
10.1016/j.ijcard.2014.04.110
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: We sought to evaluate the prognostic impact of absolute and relative kinetic changes of high-sensitivity cardiac Troponin T (hs-cTnT) in comparison to baseline hs-cTnT elevations for risk stratification in acute coronary syndrome (ACS) and non-ACS conditions with increased hs-cTnT. Methods: hs-cTnT was measured serially in patients presenting with acute symptoms to our emergency department. We assessed the prognostic performance of baseline and serial hs-cTnT concentrations in all consecutive patients with ACS (n = 406) or hs-cTnT increases not due to ACS (n = 442) within 3-6 h after admission. Results: Mortality rates were higher, albeit not statistically, in non-ACS (53/442= 12.0%) than ACS patients (36/ 406 = 8.9%). In ACS patients, receiver operating characteristics (ROC) revealed optimized cut-off values of 12.2 ng/L for absolute delta-change (AUC = 0.66, p < 0.001), 31.2 ng/L for baseline hs-cTnT (AUC = 0.71, p < 0.001) and 45.2 ng/L for maximal hs-cTnT (AUC = 0.68, p < 0.001). C-statistics showed superiority of absolute delta-changes (p = 0.0003), baseline hs-cTnT (p = 0.04) and maximal hs-cTnT (p = 0.02) compared to relative d-changes. However, the combination of baseline hs-cTnT values with either absolute or relative d-changes did not improve risk prediction compared to baseline hs-cTnT alone (p = n.s.). In non-ACS conditions, the ROC-optimized cut-off value of 46.2 ng/L for baseline hs-cTnT (AUC = 0.661, p < 0.001) was superior to absolute (p = 0.007) and relative d-changes regarding prognostication (p = 0.045). Conclusions: Our data suggest that the magnitude of baseline hs-cTnT, and not acute dynamic changes, convey superior long-term prognostic information in ACS and non-ACS conditions. Moreover, absolute and relative kinetic d-changes of hs-cTnT do not add significant incremental value in risk assessment in both conditions. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:524 / 529
页数:6
相关论文
共 50 条
  • [41] High-Sensitivity Cardiac Troponin T Elevation and Paroxysmal Supraventricular Tachycardia. Is it Always Acute Coronary Syndrome?
    Micciche, Serena
    Pelaggi, Giuseppe
    Lo Nigro, Maria Claudia
    Celeste, Simone
    Moncada, Alice
    La Cognata, Olga
    Lo Savio, Armando
    Bonanno, Salvatore
    Bellocchi, Paolo
    Agnelli, Graziella
    Curro, Alessio
    COR ET VASA, 2025, 67 (01) : 77 - 81
  • [42] Matrix Metalloproteinase-9 for the Earliest Stage Acute Coronary Syndrome - Comparison With High-Sensitivity Troponin T
    Kobayashi, Nobuaki
    Hata, Noritake
    Kume, Noriaki
    Yokoyama, Shinya
    Shinada, Takuro
    Tomita, Kazunori
    Kitamura, Mitsunobu
    Shirakabe, Akihiro
    Inami, Toru
    Yamamoto, Masanori
    Seino, Yoshihiko
    Mizuno, Kyoichi
    CIRCULATION JOURNAL, 2011, 75 (12) : 2853 - 2861
  • [43] High-sensitivity troponin testing months after an acute coronary syndrome: noise or notable results
    Kavsak, Peter
    Devereaux, P. J.
    HEART, 2019, 105 (22) : 1688 - 1690
  • [44] Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome
    Weber, Michael
    Bazzino, Oscar
    Navarro Estrada, Jose Luis
    de Miguel, Raul
    Salzberg, Simon
    Fuselli, Juan J.
    Liebetrau, Christoph
    Woelken, Mariella
    Moellmann, Helge
    Nef, Holger
    Hamm, Christian
    AMERICAN HEART JOURNAL, 2011, 162 (01) : 81 - 88
  • [45] Diagnostic and prognostic value of sex- and age-specific cutpoints for high-sensitivity Troponin T in non-ST-elevation acute coronary syndrome
    Widera, Christian
    Giannitsis, Evangelos
    Mueller-Hennessen, Matthias
    Reimann, Ines
    Guba-Quint, Anja
    Marquardt, Ivonne
    Bethmann, Kerstin
    Meyer, Sven
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 275 : 13 - 19
  • [46] High-sensitivity cardiac troponin T as a predictor of acute Total occlusion in patients with non-ST-segment elevation acute coronary syndrome
    Baro, Rocio
    Haseeb, Sohaib
    Ordonez, Santiago
    Costabel, Juan P.
    CLINICAL CARDIOLOGY, 2019, 42 (02) : 222 - 226
  • [47] PROGNOSTIC VALUE OF UNDETECTABLE HS TROPONIN T IN SUSPECTED ACUTE CORONARY SYNDROME
    Siddiqa, Ayesha
    Khan, Maleeha Mujeeeb
    Rafiq, Fareeha
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (04): : 7110 - 7114
  • [48] Prognostic Value of Undetectable hs Troponin T in Suspected Acute Coronary Syndrome
    Vafaie, Mehrshad
    Slagman, Anna
    Moeckel, Martin
    Hamm, Christian
    Huber, Kurt
    Mueller, Christian
    Vollert, Joern O.
    Blankenberg, Stefan
    Katus, Hugo A.
    Liebetrau, Christoph
    Giannitsis, Evangelos
    Searle, Julia
    AMERICAN JOURNAL OF MEDICINE, 2016, 129 (03) : 274 - +
  • [49] High-Sensitivity Troponin T vs I in Acute Coronary Syndrome: Prediction of Significant Coronary Lesions and Long-term Prognosis
    Kvisvik, Brede
    Morkrid, Lars
    Rosjo, Helge
    Cvancarova, Milada
    Rowe, Alexander D.
    Eek, Christian
    Bendz, Bjorn
    Edvardsen, Thor
    Gravning, Jorgen
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2017, 51 (03): : 395 - 407
  • [50] High-Sensitivity Troponin T vs I in Acute Coronary Syndrome: Prediction of Significant Coronary Lesions and Long-term Prognosis
    Kvisvik, Brede
    Morkrid, Lars
    Rosjo, Helge
    Cvancarova, Milada
    Rowe, Alexander D.
    Eek, Christian
    Bendz, Bjorn
    Edvardsen, Thor
    Gravning, Jorgen
    CLINICAL CHEMISTRY, 2017, 63 (02) : 552 - 562